EsoDetect: computational validation and algorithm development of a novel diagnostic and prognostic tool for dysplasia in Barrett's esophagus
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Researchers identified gene expression biomarkers to diagnose low-grade dysplasia in Barrett's esophagus (BE) and predict progression to esophageal adenocarcinoma (EAC). Machine learning algorithms using these biomarkers achieved high accuracy for early diagnosis and prognosis.
Area Of Science
- Gastroenterology
- Oncology
- Bioinformatics
Background
- Barrett's esophagus (BE) is a precursor to esophageal adenocarcinoma (EAC).
- Early diagnosis and prognosis of BE progression are critical for patient outcomes.
- Current diagnostic and prognostic tools require improvement.
Purpose Of The Study
- Identify biomarkers for diagnosing low-grade dysplasia (LGD) in BE.
- Identify biomarkers for predicting BE progression to EAC.
- Develop diagnostic and prognostic algorithms for BE management.
Main Methods
- Analyzed gene expression data from public databases (RNAseq and microarray).
- Utilized thresholding functions and F1-scores for gene ranking.
- Trained and selected machine learning classifiers (SVM) for diagnostic and prognostic applications.
Main Results
- Identified 18 diagnostic and 15 prognostic genes.
- Developed a linear SVM (diagnostic) and RBF SVM (prognostic) algorithm, each using 10 genes.
- Both algorithms achieved recall and specificity scores exceeding 0.90.
Conclusions
- Novel gene expression biomarkers and SVM algorithms show potential for early BE diagnosis and prognosis.
- The developed algorithms demonstrate superior performance compared to existing literature.
- Further clinical validation is necessary for integration into patient management.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more...
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...